Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Cancers|February 1, 2019
An Integrative Data Mining and Omics-Based Translational Model for the Identification and Validation of Oncogenic Biomarkers of Pancreatic CancerNguyen Phuoc Long, Kyung Hee Jung, Nguyen Hoang Anh, et al.
Frontiers in Oncology|April 6, 2019
Spheroid-Induced Epithelial-Mesenchymal Transition Provokes Global Alterations of Breast Cancer Lipidome: A Multi-Layered Omics AnalysisYun Pyo Kang, Jung-Ho Yoon, Nguyen Phuoc Long, et al.
Scientific Reports|May 21, 2022
Comparative analysis of mesenchymal stem cells cultivated in serum free mediaJoo Youn Lee, Min Hee Kang, Ji Eun Jang, et al.
Journal of the National Cancer Institute|October 6, 2021
A Serum Marker for Early Pancreatic Cancer With a Possible Link to DiabetesHoonsik Nam, Soon-Sun Hong, Kyung Hee Jung, et al.
American Journal of Cancer Research|October 13, 2022
A novel DDR1 inhibitor enhances the anticancer activity of gemcitabine in pancreatic cancerSoyeon Ko, Kyung Hee Jung, Young-Chan Yoon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2015
A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130Soon-Sun Hong, Jung Ho Choi, Sung Yoon Lee, et al.
The Journal of Sexual Medicine|May 29, 2009
IN-1130, a novel transforming growth factor-beta type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's diseaseJi-Kan Ryu, Shuguang Piao, Hwa-Yean Shin, et al.
Cancer Letters|March 21, 2021
Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escapeJi Eun Lee, Yeo Wool Kang, Kyung Hee Jung, et al.
EMBO Molecular Medicine|July 9, 2020
ANGPTL4 exacerbates pancreatitis by augmenting acinar cell injury through upregulation of C5aKyung Hee Jung, Mi Kwon Son, Hong Hua Yan, et al.
Cell Research|May 9, 2015
Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeuticsGi-Bang Koo, Michael J Morgan, Da-Gyum Lee, et al.
Pageof 18